agilon health (NYSE:AGL) Trading Down 7.8% – What’s Next?

Shares of agilon health, inc. (NYSE:AGL) were down 7.8% on Tuesday . The company traded as low as $2.02 and last traded at $2.02. Approximately 1,872,278 shares traded hands during trading, a decline of 61% from the average daily volume of 4,848,195 shares. The stock had previously closed at $2.19.

Wall Street Analyst Weigh In

AGL has been the topic of a number of recent research reports. Sanford C. Bernstein initiated coverage on agilon health in a research note on Wednesday, December 11th. They issued a “market perform” rating and a $2.50 target price on the stock. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. TD Cowen lowered their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Finally, Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $4.28.

agilon health Stock Performance

The business’s fifty day moving average is $2.34 and its two-hundred day moving average is $4.28. The stock has a market capitalization of $774.59 million, a PE ratio of -2.00 and a beta of 0.51. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the previous year, the business earned ($0.06) earnings per share. As a group, research analysts anticipate that agilon health, inc. will post -0.52 EPS for the current fiscal year.

Insider Activity

In other news, Director Diana Mckenzie bought 12,500 shares of the stock in a transaction on Monday, November 25th. The stock was acquired at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John William Wulf bought 45,000 shares of the company’s stock in a transaction on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock valued at $198,100 in the last ninety days. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of large investors have recently added to or reduced their stakes in AGL. Arizona State Retirement System lifted its position in agilon health by 2.5% during the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after acquiring an additional 2,070 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in agilon health in the third quarter valued at about $28,000. Signaturefd LLC boosted its holdings in agilon health by 166.2% in the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after acquiring an additional 7,398 shares in the last quarter. Wedbush Securities Inc. grew its stake in shares of agilon health by 72.6% during the second quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock worth $135,000 after acquiring an additional 8,710 shares during the last quarter. Finally, Checchi Capital Advisers LLC increased its holdings in shares of agilon health by 3.3% during the second quarter. Checchi Capital Advisers LLC now owns 273,280 shares of the company’s stock valued at $1,787,000 after acquiring an additional 8,823 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.